http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202235081-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259de1b1b6c5512868ec29379824a1c1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D201-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
filingDate 2021-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb3cf8775af11f9e330fa8fae263af10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c347fd993a5071bb6e2ad8bf232575d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98adc07c197ec437570a5499ef753b97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2317f0801e1573f2a901a9c68477ce38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcdd1739654b3901e2fd55e1b8b68f53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66fb620832eb3bc55f63fdc22ab85f7b
publicationDate 2022-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-202235081-A
titleOfInvention Crystalline solid meglumine salt inhibitor of bcl and methods of making and using same
abstract Aspects of the disclosure include crystalline solid meglumine salts of (R)-5-(4-chlorophenyl)-1-isopropyl-2-methyl-4-(3-(4-(4-((4-((1-(phenylthio)-4-(4-((phosphonooxy)methyl)piperidin-1-yl)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonamido)phenyl)piperazin-1-yl)phenyl)-1H-pyrrole-3-carboxylic acid. Pharmaceutical compositions having one or more of the subject crystalline solid meglumine salt compounds and methods for administering the crystalline solid meglumine salt compounds to a subject are also described. Methods for preparing the subject crystalline sold meglumine salt compounds are also provided.
priorityDate 2020-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567

Total number of triples: 37.